June 30, 2020 / 12:30 PM / 4 days ago

BRIEF-Monopar And Northstar Announce Filing Of Provisional Patent Protecting Development And Use Of Radio-Immuno-Therapeutics Targeting Severe COVID-19 Through uPAR

June 30 (Reuters) - Monopar Therapeutics Inc:

* MONOPAR AND NORTHSTAR ANNOUNCE FILING OF PROVISIONAL PATENT PROTECTING DEVELOPMENT AND USE OF RADIO-IMMUNO-THERAPEUTICS (RITS) TARGETING SEVERE COVID-19 THROUGH UPAR Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below